Worst performer by a long way was TAP:Taptica in my cursed trading account. To think I could have sold for £100 profit if I hadn't been greedy. I really don't have a clue about trading. They dropped 40% after their CEO resigned as he's being investigated for something dodgy. I don't see why this caused such a drop as it doesn't affect their profitability, and if I did have some spare cash in my trading fund now would seem to be the right time to buy.
For no particular reason SBTX:SkinBioTherapeutics fell a massive 22% this week. The only thing I can pin it on is the CEO confirming they would need another cash raise at some point. That was stated at IPO, so I don't see why that would trigger a sell-off, unless some recent investors weren't aware. I have £2K arriving in my SIPP next week, and if these stay at the current price I'll be topping up.
RED:RedT Energy are in a downward spiral at the moment, falling 10% last week and another 9% this week. I'm now 56% down and not sure if I'll ever see a profit. Can they make enough from each unit to go into the black?
IKA:Ilika had a bit of a rally a few months ago but it's all gone now and they dropped another 6% this week to go 67% down. My holding is only worth £220 though, so I may as well hang on and hope someone eventually wants to buy their stuff.
MTFB:Motif Bio was looking a superb investment when they passed phase III trials and submitted their application to FDA. Now they are 22% down - is that just because investors are impatient? They've done the hard stuff, now it's just a case of waiting for approval and doing a deal with one of the big boys. At this rate one of those big boys will simply buy out the whole company for a bargain and shareholders will be screwed.
PAF:Pan African Resources had a good week, climbing 6% and going £255 into profit. I'm still expecting these to double when production from their new project is announced.
Share of the Week is JLP:Jubilee Metals which climbed 7% but is still only 2.5p a share and down by 44%. It's been sliding for months, so I wonder what's caused the recovery? In the past shares like this have shown a tendency to be a tad leaky, so it's possible there will be an announcement on Kabwe progress, or maybe they've finally worked out what to do with Tjate?
The right side of the line - but for how long?
Here's the performance of the ISA and share accounts
| Weekly Change | |||
| Cash | £30.05 | -£3.75 | |
| Portfolio cost | £56,958.55 | +£0 | |
| Portfolio sell value (bid price - commission) | £57,755.36 | (1.4%) | -£1,972.55 |
| Potential profits | £11,366.93 | -£1,517.88 | |
| Yr 4 Dividends | £60.50 | +£0 | |
| Yr 4 Profit from sales | £814.53 | +£0 | |
| Yr 4 Average monthly cash profit | £206.14 | (4.3%) | -£13.08 |
| Total Dividends | £1,298.83 | +£0 | |
| Total Profit from sales | £19,511.65 | +£0 | |
| Average monthly cash profit | £514.15 | (10.8%) | -£3.07 |
| (Sold stocks profit + Dividends - Fees / Months) |
Cash dropped from monthly ISA charge, and all the drop in profit was from OPTI:Optibiotix falling 4p. Losses deepened by around £450 too, so a generally bad week.
Only just staying above the line
The SIPP looks like this after week 158
| Weekly Change | |||
| Cash | £138.64 | -£15.08 | |
| Portfolio cost | £35,825.45 | +£0 | |
| Portfolio sell value (bid price - commission) | £39,252.41 | (11.9%) | -£837.21 |
| Potential profits | £7,254.02 | -£834.53 | |
| Yr 4 Dividends | £0 | +£0 | |
| Yr 4 Interest | £0 | +£0 | |
| Yr 4 Profit from sales | £0 | +£0 | |
| Yr 4 Average monthly cash profit | £0 | (0%) | +£0 |
| Total Dividends | £1,342.25 | +£0 | |
| Total Interest | £0.03 | +£0 | |
| Total Profit from sales | £10,544.92 | +£0 | |
| Average monthly cash profit | £318.51 | (10.7%) | -£2.44 |
| (Sold stocks profit + Dividends - Fees / Months) |
Monthly charge has gone up quite a bit since adding the extra £8K to the cost/value. Losses were pretty much restricted to falling profit, with everything dropping except PAF:Pan African Resources. Really hoping my next £2K transfer will arrive next week. My current plan is to split it in half between SBTX:SkinBioTherapeutics and MTFB:Motif Bio, as I believe both are cheap right now and news can't be far away.
Much more healthy and a decent buffer, with four of the 10 holdings in profit.
Here's the trading account after week 124
| Weekly Change | |||
| Cash | £18.80 | +£0 | |
| Portfolio cost | £2,321.29 | +£0 | |
| Portfolio sell value (bid price - commission) | £1,378.16 | (-40.6%) | -£202.54 |
| Potential profits | £0 | +£0 | |
| Year 3 Dividends | £17.33 | +£0 | |
| Year 3 Profit | £177.06 | +£0 | |
| Yr 3 Average monthly cash profit | £42.12 | (21.8%) | -£2.21 |
| Dividends | £18.48 | +£0 | |
| Profit from sales | -£64.29 | +£0 | |
| Average monthly cash profit | -£1.60 | (-0.8%) | +£0.01 |
| (Sold stocks profit + Dividends - Fees / Months) |
Really, really poor. TAP:Taptica was my only share anywhere near profit and now it's toxic. I'm destined never to make any money from this account.
Brilliant idea to add another £2,000 and start again from scratch - at least I was able to extract some of the injection cash after selling KOD:Kodal Minerals for a big profit, but since then it's been diabolical.
OPTI:Optibiotix promised some more surprises before Christmas. That's getting quite close now, and with Go Figure muesli pots becoming available next week, can we hope for some sort of retail launch? That would be an amazing Christmas present.
No comments:
Post a Comment